Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | PPARA | Q07869 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 10/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 6/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7788351 | 0.92 | HIF1A (0.42) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL7788357 | 0.92 | HIF1A (0.42) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL7795491 | 0.90 | KMT2A (0.41) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL7795487 | 0.90 | KMT2A (0.41) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL7788358 | 0.81 | MEN1 (0.41) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL3110345 | 0.81 | PPARG (0.54) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL7070310 | 0.80 | PPARG (0.43) | PPARGPPARAMEN1KMT2ATBXA2R | |
| SCHEMBL7073241 | 0.79 | PPARG (0.42) | PPARGPPARAMEN1KMT2ATBXA2R | |
| SCHEMBL2792522 | 0.79 | HIF1A (0.52) | PPARGPPARAMEN1KMT2ANPSR1 | |
| SCHEMBL5112727 | 0.79 | HIF1A (0.52) | PPARGPPARAMEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1095013-B1 | PHENYL-METHOXYIMINO-ACETIC ACID DERIVATIVES AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2003-06-18 | — | — | EP | disclosed |
| US-20010018452-A1 | Phenyl-methoxyimino-acetic acid derivatives as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2001-08-30 | — | — | US | disclosed |
| EP-1095013-A1 | PHENYL-METHOXYIMINO-ACETIC ACID DERIVATIVES AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2001-05-02 | — | — | EP | disclosed |
| WO-2000003974-A1 | PHENYL-METHOXYIMINO-ACETIC ACID DERIVATIVES AS PESTICIDES | SYGENTA PARTICIPATIONS AG (CH) | 2000-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018452-A1 | Phenyl-methoxyimino-acetic acid derivatives as pesticides | HAO1, CYP1A1, HAO2 | PPARG 1217/4885PPARA 1474/4885MEN1 1075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.